Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04587336 · ClinicalTrials.gov registry record
Tailored Approaches to Reduce Distress and Improve Self-Management for Veterans With Diabetes
A clinical trial of Diabetes and Self-management, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 225
- Enrollment target
- 1
- Study location
NCT04587336: Completed study of Diabetes and Self-management, sponsored by VA Office of Research and Development.
NCT04587336 is a study of Diabetes and Self-management that has completed, run by VA Office of Research and Development. The registered enrollment target is 225 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04587336, a study of Diabetes and Self-management, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
Veterans with diabetes may become overwhelmed with the self-management behaviors needed to maintain optimal health. Veterans may experience diabetes distress (DD), a concept distinct from depression, due the amount and frequency of these behaviors. DD negatively influences the Veteran's engagement in self-management and subsequent HbA1c levels. Previous interventions do not tailor T2D self-management information to a Veteran's DD, which may be one reason interventions are ineffective at reducing DD. This proposal examines the impact of correlating factors (e.g., sociodemographic, psychosocial, and environmental) on DD using surveys and semi-structured interviews. This proposal will prepare Allison Lewinski, PhD, MPH, RN for a career as a scientist at VHA focused on developing methods to improve health outcomes among Veterans.
Primary Outcome
Scale used: 17 item Diabetes Distress Scale. Minimum value 1, Maximum value 6 Scoring is: \< 2.0 is little or no distress; 2.0-2.9 is moderate distress; and ≥ 3.0 is high distress. Higher scores indicate higher diabetes distress or worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Qualitative Interviews
- BEHAVIORAL Cognitive Interview
- BEHAVIORAL Baseline Survey
Study Locations (1)
North Carolina
- Durham VA Medical Center, Durham, NC - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2025-03-31 |
What the finished NCT04587336 record still lists
NCT04587336 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Qualitative Interviews is the first listed.
NCT04587336 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04587336 about?
NCT04587336 is a clinical study titled "Tailored Approaches to Reduce Distress and Improve Self-Management for Veterans With Diabetes". Veterans with diabetes may become overwhelmed with the self-management behaviors needed to maintain optimal health. Veterans may experience diabetes distress (DD), a concept distinct from depression, due the amount and frequency of these behaviors. DD negatively influences the Veteran's engagement i...
What is the current status of trial NCT04587336?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2020-08-24. Estimated completion is 2025-03-31.
What conditions does trial NCT04587336 study?
This clinical trial studies the following conditions: Diabetes, Self-management, Diabetes Distress, Veteran.
What interventions are being tested in trial NCT04587336?
The interventions under investigation include: Qualitative Interviews (BEHAVIORAL), Cognitive Interview (BEHAVIORAL), Baseline Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT04587336?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04587336 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04587336's enrollment target sits among peer trials
225 141st of 338 higher than 197 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI